The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
Open accessAbstract
INTRODUCTION: A selective combination of C-reactive protein and albumin (termed the modified Glasgow Prognostic Score, mGPS) has been shown to have prognostic value, independent of tumour stage, in lung, gastrointestinal and renal cancers. It is also of interest that liver function tests such as bilirubin, alkaline phosphatase and γ-glutamyl transferase, as well as serum calcium, have also been reported to predict cancer survival. The aim of the present study was to examine the relationship between an inflammation-based prognostic score (mGPS), biochemical parameters, tumour site and survival in a large cohort of patients with cancer. METHODS: Patients (n=21,669) who had an incidental blood sample taken between 2000 and 2006 for C-reactive protein, albumin and calcium (and liver function tests where available) and a diagnosis of cancer were identified. Of this group 9608 patients who had an ongoing malignant process were studied (sampled within 2 years before diagnosis). Also a subgroup of 5397 sampled at the time of diagnosis (sampled within 2 months prior to diagnosis) were examined. Cancers were grouped by tumour site in accordance with International Classification of Diseases 10 (ICD 10). RESULTS: On follow up, there were 6005 (63%) deaths of which 5122 (53%) were cancer deaths. The median time from blood sampling to diagnosis was 1.4 months. Increasing age, male gender and increasing deprivation was associated with a reduced 5-year overall and cancer-specific survival (all P<0.001). An elevated mGPS, adjusted calcium, bilirubin, alkaline phosphatase, aspartate transaminase, alanine transaminase and γ-glutamyl transferase were associated with a reduced 5-year overall and cancer-specific survival (independent of age, sex and deprivation in all patients sampled), as well as within the time of diagnosis subgroup (all P<0.001). An increasing mGPS was predictive of a reduced cancer-specific survival in all cancers (all P<0.001). CONCLUSION: The results of the present study indicate that the mGPS is a powerful prognostic factor when compared with other biochemical parameters and independent of tumour site in patients with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,890
Stewart, B. W., & Kleihues, P. (2003) · Cited by 2,386
Systemic inflammation, nutritional status and survival in patients with cancer
McMillan, D. C. (2009) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32832a7902 · Cited by 1,001
Self-citationRoxburgh, C. S., & McMillan, D. C. (2010) · Future Oncology · doi:10.2217/fon.09.136 · Cited by 998
Self-citationWilkinson, E. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00737-4 · Cited by 951
Boyle, P., & Levin, B. L. (2009) · Cited by 770
Tumour immunity: effector response to tumour and role of the microenvironment
Mantovani, A., Romero, P., Palucka, A. K., & Marincola, F. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60241-x · Cited by 537
McMillan, D. C., Crozier, J. E. M., Canna, K., Angerson, W. J., & McArdle, C. S. (2007) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0259-6 · Cited by 533
Self-citationMcMillan, D. C. (2008) · Proceedings of the Nutrition Society · doi:10.1017/s0029665108007131 · Cited by 472
Self-citationForrest, L. M., McMillan, D. C., McArdle, C. S., Angerson, W. J., & Dunlop, D. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601789 · Cited by 359
Self-citationRelation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality
Tonelli, M., Curhan, G., Pfeffer, M., Sacks, F., Thadhani, R., Melamed, M. L., Wiebe, N., & Muntner, P. (2009) · Circulation · doi:10.1161/circulationaha.109.851873 · Cited by 280
McDonald, B., Spicer, J., Giannais, B., Fallavollita, L., Brodt, P., & Ferri, L. E. (2009) · International Journal of Cancer · doi:10.1002/ijc.24409 · Cited by 222
Proctor, M. J., Talwar, D., Balmar, S. M., O'Reilly, D. S. J., Foulis, A. K., Horgan, P. G., Morrison, D. S., & McMillan, D. C. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605855 · Cited by 204
Self-citationSerum bilirubin and 10-year mortality risk in a Belgian population
Temme, E. H. M., Zhang, J., Schouten, E. G., & Kesteloot, H. (2001) · Cancer Causes & Control · doi:10.1023/a:1013794407325 · Cited by 197
Gamma Glutamyltransferase and Long-Term Survival: Is It Just the Liver?
Kazemi-Shirazi, L., Endler, G., Winkler, S., et al. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.081620 · Cited by 146
Serum calcium and survival in a large health screening program
Leifsson, B. G., & Åhrén, B. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.6.8964843 · Cited by 138
The economics of cancer care in the UK
Bosanquet, N., & Sikora, K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01569-4 · Cited by 66
Tenesa, A., Τheodoratou, E., Din, F. V. N., Farrington, S. M., Cetnarskyj, R., Barnetson, R. A., Porteous, M. E., Campbell, H., & Dunlop, M. G. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0439 · Cited by 40
Cited by
Cancer cachexia: understanding the molecular basis
Argilés, J. M., Busquets, S., Stemmler, B., & López-Soriano, F. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3829 · Cited by 1,517
McMillan, D. C. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.08.003 · Cited by 1,398
Self-citationProctor, M. J., Morrison, D. S., Talwar, D., Balmer, S. M., Fletcher, C. D., O’Reilly, D. S. J., Foulis, A. K., Horgan, P. G., & McMillan, D. C. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.028 · Cited by 757
Self-citationA derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
Proctor, M. J., McMillan, D. C., Morrison, D. S., Fletcher, C. D., Horgan, P. G., & Clarke, S. J. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.292 · Cited by 508
Self-citationStotz, M., Gerger, A., Eisner, F., Szkandera, J., Loibner, H., L Ress, A., Kornprat, P., A Zoughbi, W., Seggewies, F. S., Lackner, C., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.332 · Cited by 490
Metadata
- Authors
- Proctor, M. J., Morrison, D. S., Talwar, D., Balmer, S. M., O'Reilly, D. S. J., Foulis, A. K., Horgan, P. G., & McMillan, D. C.
- Venue
- British Journal of Cancer
- Published
- 2011-01-25
- Volume
- 104
- Issue
- 4
- Pages
- 726-734
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2133824413
- Cited by
- 531
- References
- 19
- FWCI
- 10.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.